# Amgen Inc. (AMGN) — Q1-2015 Earnings Results

**Report date:** 2015-04-21 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q1-2015

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Up 1.5%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.48 | N/A | +19.98% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed confidence in the company's core products and their potential for growth. They emphasized the importance of continued innovation.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They noted ongoing investments in research and development.

> The focus remains on delivering innovative solutions for patients.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Amgen's strong EPS performance indicates better-than-expected profitability, contributing to a positive stock reaction of 1.5%. Investors may be encouraged by management's focus on innovation and strong product performance, even without specific revenue figures or guidance for the future.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q1-2015_